St. Jude Medical Inc (STJ.N)

STJ.N on New York Stock Exchange

68.16USD
1:24am IST
Price Change (% chg)

$1.36 (+2.04%)
Prev Close
$66.80
Open
$66.83
Day's High
$68.16
Day's Low
$66.83
Volume
366,055
Avg. Vol
479,881
52-wk High
$71.89
52-wk Low
$55.00

STJ.N

Chart for STJ.N

About

St. Jude Medical, Inc. (St. Jude) develops, manufactures and distributes cardiovascular medical devices. Its principal products in each therapy area are: Cardiac Rhythm Management - tachycardia implantable cardioverter defibrillator systems (ICDs) and bradycardia pacemaker systems (pacemakers); Cardiovascular - vascular... (more)

Overall

Beta: 1.32
Market Cap (Mil.): $18,375.62
Shares Outstanding (Mil.): 285.91
Dividend: 0.27
Yield (%): 1.68

Financials

Search Stocks

CORRECTED-UPDATE 2-St. Jude Medical lowers forecast; shares fall

(Corrects low end of pvs revenue forecast and U.S. pacemaker and defibrillator growth in 4th and 9th paragraphs)

17 Oct 2014

UPDATE 2-St. Jude Medical lowers forecast; shares fall

(Adds CFO, analyst comment, full-year forecast; updates shares)

15 Oct 2014

St.Jude Medical adjusted profit rises

Oct 15 - Heart device maker St. Jude Medical Inc reported a lower quarterly profit, as it took a $39 million charge related to impairment and restructuring, despite a rise in sales of its devices to treat abnormal heart rhythms.

15 Oct 2014

Fitch Affirms St. Jude Medical's at 'A'; Outlook Stable

(The following statement was released by the rating agency) CHICAGO, August 20 (Fitch) Fitch Ratings has affirmed St. Jude Medical, Inc.'s (STJ) Issuer Default Rating (IDR) at 'A' with a Stable Rating Outlook. Fitch has also affirmed the company's short-term IDR at 'F1'. A full list of Fitch's rating actions is available at the end of this release. The ratings apply to approximately $4.21 billion of debt outstanding as of June 28, 2014. KEY RATING DRIVERS Fitch's rating actions reflect the f

20 Aug 2014

St. Jude not keen to join inversion deal craze

- Heart device maker St. Jude Medical Inc STJ.N said it has no plans to jump on the consolidation bandwagon that has swept the healthcare sector in recent months and is not seeking the type of "inversion" deal increasingly popular among U.S. companies seeking to lower taxes by re-basing abroad.

17 Jul 2014

UPDATE 2-St. Jude not keen to join inversion deal craze

July 16 - Heart device maker St. Jude Medical Inc said it has no plans to jump on the consolidation bandwagon that has swept the healthcare sector in recent months and is not seeking the type of "inversion" deal increasingly popular among U.S. companies seeking to lower taxes by re-basing abroad.

17 Jul 2014

St Jude Medical's quarterly profit doubles as expenses fall

July 16 - Heart device maker St. Jude Medical Inc reported a quarterly net profit that more than doubled as expenses fell.

16 Jul 2014

CORRECTED-UPDATE 1-FDA says manufacturing issues at St. Jude plant resolved

(Corrects second paragraph to remove reference to "Riata" leads)

03 Jul 2014

CORRECTED-FDA says manufacturing issues at St. Jude plant resolved

(Corrects second paragraph to remove reference to "Riata" leads)

03 Jul 2014

FDA says manufacturing issues at St. Jude plant resolved

- St. Jude Medical Inc said the U.S. Food and Drug Administration notified the company that issues regarding its Sylmar, California-based manufacturing plant have been resolved.

02 Jul 2014

Competitors

Earnings vs. Estimates

Search Stocks